About Us | Privacy | Site Map
February 10, 2012
Font Size
A
A
A

C Reactive Protein Blood Test (CRP) (cont.)

Medical Author:
Medical Editor:

C-reactive Protein and Cardiovascular Disease

Based on the review of the published data, the CDC and the American Heart Association (AHA) have recommended the following guidelines for assessment of cardiovascular disease risk:

  • CRP levels of 1 mg per liter or lower are considered low risk for cardiovascular disease.

  • CRP levels of 1-3 mg per liter are considered moderate risk for cardiovascular disease.

  • CRP levels greater than 3 mg per liter are considered high risk for cardiovascular disease.

  • CRP levels greater than 10 mg per liter may suggest an acute coronary process, such as heart attack (acute myocardial infarction).

The known risk factors for cardiovascular disease are:

High c-reactive protein levels may predict a higher risk for cardiovascular disease alone or in combination with these other known predictors. Some studies have suggested an elevated risk for cardiovascular disease associated with elevated c-reactive protein levels even after correcting for the other risk factors.

A relation also seems to exist between an increased c-reactive protein level and the presence of known cardiac risk factors, such as advanced age, diabetes mellitus, elevated cholesterol, increased body mass index (BMI), obesity, and cigarette smoking. This may be possibly related to ongoing inflammatory atherosclerosis in these individuals because of their risk factors.

Despite these associations, research has not clearly and consistently established c-reactive protein as an independent risk factor for cardiovascular disease, as the data seem to be inconsistent from different studies. It has been proposed that elevated c-reactive protein is an independent predictor of atherosclerosis among healthy men and women.

statins) have been linked to lowering of c-reactive protein levels in individuals with high cholesterol. The fall of c-reactive protein levels may occur even without significant improvement in cholesterol levels.

The use of aspirin in healthy individuals was not shown to reduce c-reactive protein levels significantly. However, in patients with cardiovascular disease and elevated c-reactive protein, the reduction of cardiovascular risk and c-reactive protein levels was noted after aspirin use.

Some oral diabetes medicines, thiazolidinediones [rosiglitazone (Avandia) and pioglitazone (Actos), were noted to reduce c-reactive protein levels in patients with or without type 2 diabetes. This effect was independent of their glucose-lowering effects.

Heart Health

Get the latest treatment options.




Medical Dictionary


Use Pill Finder Find it Now

Pill Identifier on RxList

  • quick,
    easy,
    pill identification

Find a Local Pharmacy

  • including
    24 hour
    pharmacies